指南与共识耳科与耳神经

耳鸣临床实践指南更新版执行摘要

Executive Summary of the Clinical Practice Guideline on Tinnitus Update.
指南 / 共识 · Otolaryngol Head Neck Surg · 2026-01-01

该指南由Otolaryngol Head Neck Surg发布,针对18岁及以上持续性(≥6个月)且困扰性耳鸣的成人,提供基于证据的评估与管理建议,强调区分困扰性与非困扰性耳鸣、询问自伤风险、不常规进行神经影像学检查,并推荐认知行为疗法等。

要点

  • 区分困扰性与非困扰性耳鸣,并询问自伤风险。
  • 不常规进行神经影像学检查,除非有特定警示特征。
  • 推荐认知行为疗法,不推荐抗抑郁药等药物。

核心结论

  • 指南为持续性、困扰性耳鸣成人提供评估与管理框架,强调识别可治疗病因及减少自伤风险,并推荐认知行为疗法等干预。

研究设计与样本

  • 指南更新小组制定,目标人群为18岁及以上持续性(≥6个月)且困扰性耳鸣的成人,排除有明确病因(除感音神经性听力损失外)及其他特定情况的患者。

主要发现

  • 多数耳鸣患者伴有感音神经性听力损失,多因老化、噪声暴露或声创伤所致。
  • 耳鸣可为中耳疾病、内耳及听神经病变等多种听觉及非听觉系统疾病的症状。

关键数值与推荐

  • 强烈推荐:区分困扰性与非困扰性耳鸣(KAS 2)。
  • 强烈推荐:询问困扰性耳鸣患者的自伤风险(KAS 3)。
  • 强烈推荐:不常规进行神经影像学检查以评估耳鸣,除非有特定警示特征(KAS 6)。
  • 推荐:对听力困难且持续性困扰性耳鸣患者推荐助听器评估(KAS 8)。
  • 推荐:对持续性困扰性耳鸣患者推荐认知行为疗法(KAS 11)。

临床怎么用

  • 临床医生应通过针对性病史和体格检查评估耳鸣患者,并获取全面的听力学评估。
  • 应教育患者耳鸣的自然史、影响及管理策略,并评估干预效果。
  • 对符合听力标准者转诊人工耳蜗评估,可考虑声 enrichment 和双模式神经调控。

局限性

  • 指南不适用于有明确 causative 诊断(除感音神经性听力损失外)的患者,因随机对照试验多排除此类人群。
  • 不涵盖客观性耳鸣和搏动性耳鸣的综合管理。
  • 不适用于短暂性耳部噪声(持续少于5分钟)及与复杂听幻觉或精神病/癫痫相关的耳鸣。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Tinnitus is the perception of sound without an external source. More than 50 million people in the United States have reported experiencing tinnitus, resulting in an estimated prevalence of 10% to 15% in adults. The focus of this guideline is on tinnitus that is both bothersome and persistent (lasting 6 months or longer), which often negatively affects the patient's quality of life. The target audience for the guideline is any clinician, including allied health professionals, involved in managing patients with tinnitus. The target patient population is limited to adults (18 years and older) with tinnitus that is persistent and bothersome. PURPOSE: The purpose of this guideline is to provide and update evidence-based recommendations for clinicians managing patients with tinnitus. The target audience for this guideline is any clinician involved in managing patients with tinnitus. People with tinnitus may be evaluated by a variety of health care providers, including primary care clinicians, specialty clinicians, and allied health professionals including audiologists and clinical psychologists. The target patient population is limited to adults (18 years and older) with tinnitus that is persistent and bothersome. Most people with tinnitus have associated hearing loss, such as sensorineural hearing loss (SNHL) secondary to aging (presbycusis), noise exposure (noise-induced hearing loss), or acoustic trauma. Tinnitus can also be a symptom of numerous auditory and non-auditory system disorders, ranging from middle ear diseases, such as otosclerosis and eustachian tube dysfunction, to inner ear and auditory nerve pathologies such as Ménière's disease and vestibular schwannoma. Nonauditory system disorders that can cause tinnitus include vascular anomalies, myoclonus, and intracranial hypertension. The Guideline Update Group (GUG) placed emphasis on the need for thorough clinical evaluation to identify these potentially treatable and sometimes serious disorders. However, patients with identifiable causative diagnoses other than sensorineural hearing loss are excluded from this guideline as they are excluded from nearly all randomized controlled trials of tinnitus management, making it impossible to generalize trial results to these patients. Nevertheless, clinicians should decide whether to apply the recommendations of this guideline to patients with these conditions on an individualized basis. The guideline also underscores the need to distinguish between subjective, objective, and pulsatile tinnitus to further direct patient evaluation and management. Comprehensive management of objective tinnitus and pulsatile tinnitus is not within the scope of this guideline. Pulsatile tinnitus is the perception of a rhythmic sound in the absence of an external source that may be pulse-synchronous, which is often but not always related to vascular causes, or pulse-asynchronous, which is typically associated with mechanical causes such as palatal or middle ear myoclonus.1 Further, the guideline does not apply to transient ear noise, which is the sudden perception of a tonal or ringing sound in 1 ear, lasting fewer than 5 minutes, that may be accompanied by a sense of hearing loss or aural fullness, as it does not typically require clinical management.2 The guideline also excludes patients with tinnitus related to complex auditory hallucinations or hallucinations related to psychotic or seizure disorders. This is an update to an evidence-based clinical guideline developed for the evaluation and management of tinnitus. This updated guideline provides clinicians with a logical framework to improve patient care and mitigate the personal and social effects of persistent, bothersome tinnitus. The first part of the guideline is focused on the clinical evaluation of patients with tinnitus, including the history, physical exam, and selection and timing of diagnostic testing and specialty referral to identify potential underlying treatable pathology and reduce the risk of self-harm. The remainder of the guideline is focused on the evaluation and treatment of patients with persistent, bothersome tinnitus, with recommendations to evaluate and measure its effects as well as to determine the most appropriate interventions to improve symptoms and quality of life. ACTION STATEMENTS: The Guideline Update Group made strong recommendations for the following Key Action Statements (KAS): Clinicians should distinguish patients with bothersome tinnitus from patients with nonbothersome tinnitus (KAS 2). Clinicians should inquire about risks for self-harm in a patient with bothersome tinnitus (KAS 3). Clinicians should not obtain neuroradiologic imaging in patients with tinnitus specifically to evaluate the tinnitus unless specific concerning features are present (KAS 6). The Guideline Update Group made recommendations for the following KASs: Clinicians should perform a targeted history and physical examination at the initial evaluation of a patient with tinnitus (KAS 1). Clinicians should obtain a comprehensive audiological evaluation in patients with tinnitus (KAS 5). Clinicians should educate patients with tinnitus about the natural history and effects of, and management strategies for tinnitus (KAS 7). Clinicians should recommend a hearing aid evaluation for patients with hearing difficulties and persistent, bothersome tinnitus (KAS 8). Clinicians should refer patients with persistent, bothersome tinnitus for cochlear implant evaluation when they meet audiologic criteria for referral (KAS 9). Clinicians should recommend Cognitive Behavioral Therapy (CBT) to patients with persistent, bothersome tinnitus (KAS 11). Clinicians or their designee should assess and document outcomes of interventions in patients with persistent, bothersome tinnitus (KAS 15). The Guideline Update Group made recommendations against for the following KASs: Clinicians should not routinely recommend antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for a primary indication of treating persistent, bothersome tinnitus (KAS 12). Clinicians should not recommend dietary supplements for the primary indication of persistent, bothersome tinnitus (KAS 13). Clinicians should not recommend repetitive transcranial magnetic stimulation (rTMS) for the treatment of patients with persistent, bothersome tinnitus (KAS 14A). The Guideline Update Group offered options for the following KASs: Clinicians may inquire about somatosensory features in patients with persistent, bothersome tinnitus (KAS 4). Clinicians may recommend sound enrichment to patients with persistent, bothersome tinnitus (KAS 10). Clinicians may offer bimodal neuromodulation to patients with persistent, bothersome tinnitus (KAS 14B).

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Adams ME, Cramer JD, Tunkel DE, et al. Executive Summary of the Clinical Practice Guideline on Tinnitus Update. Otolaryngol Head Neck Surg. 2026. PMID: 42861486. doi:10.1002/ohn.70418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。